B
BCRX//CIK 0000882796
BIOCRYST PHARMACEUTICALS INC
Market Data
$9.02+$0.39 (+4.52%)
BCRX · Last trade
Prev Close
$8.63
Range (30d)
$8.22 – $9.81
Recent Filings
- 10-K15.3 MBBIOCRYST PHARMACEUTICALS INCFeb 26, 4:03 PM ET·0001628280-26-012240
- 8-K435.5 KBBIOCRYST PHARMACEUTICALS INCFeb 26, 7:19 AM ET·0001171843-26-001119
- 8-K/A189.4 KBBIOCRYST PHARMACEUTICALS INCJan 23, 4:32 PM ET·0001171843-26-000405
- 8-K2.1 MBBIOCRYST PHARMACEUTICALS INCJan 23, 4:30 PM ET·0001140361-26-002200
- 8-K246.1 KBBIOCRYST PHARMACEUTICALS INCJan 12, 4:28 PM ET·0001171843-26-000213
- 8-K185.4 KBBIOCRYST PHARMACEUTICALS INCJan 9, 7:01 AM ET·0001171843-26-000154
- 8-K260.6 KBBIOCRYST PHARMACEUTICALS INCDec 12, 7:51 AM ET·0001171843-25-007909
- 8-K186.4 KBBIOCRYST PHARMACEUTICALS INCDec 11, 7:25 AM ET·0001171843-25-007878
- 8-K668.5 KBBIOCRYST PHARMACEUTICALS INCDec 3, 8:00 AM ET·0001140361-25-044110
- 10-Q13.5 MBBIOCRYST PHARMACEUTICALS INCNov 4, 4:02 PM ET·0001628280-25-048785
Insiders
10- 14159, L.P.10% Owner
- 667, L.P.10% Owner
- ABERCROMBIE GEORGE BDirector
- ALEXANDER W JAMESSR. VP, Chief Medical Officer
- ASELAGE STEVEDirector
- Babu Yarlagadda SVP Drug Discovery
- Baker Biotech Capital (GP), LLC10% Owner
- Baker Bros. Advisors (GP) LLC10% Owner
- BAKER BROS. ADVISORS LP10% Owner
- Baker Bros. Capital (GP), LLC10% Owner
Tickers
Addresses
business
4505 EMPEROR BOULEVARD SUITE 200
DURHAM, NC, 27703
mailing
4505 EMPEROR BOULEVARD SUITE 200
DURHAM, NC, 27703